| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59762-4030-1 | 59762-4030 | HUMAN PRESCRIPTION DRUG | GABAPENTIN | gabapentin | CAPSULE | ORAL | 20190603 | 20240531 | NDA AUTHORIZED GENERIC | NDA020235 | Greenstone LLC | GABAPENTIN | 100 mg/1 | 100 CAPSULE in 1 BOTTLE (59762-4030-1) |
| 0071-0806-24 | 0071-0806 | HUMAN PRESCRIPTION DRUG | Neurontin | gabapentin | CAPSULE | ORAL | 19931230 | N/A | NDA | NDA020235 | Parke-Davis Div of Pfizer Inc | GABAPENTIN | 400 mg/1 | 100 CAPSULE in 1 BOTTLE (0071-0806-24) |
| 0071-0805-24 | 0071-0805 | HUMAN PRESCRIPTION DRUG | Neurontin | gabapentin | CAPSULE | ORAL | 19931230 | N/A | NDA | NDA020235 | Parke-Davis Div of Pfizer Inc | GABAPENTIN | 300 mg/1 | 100 CAPSULE in 1 BOTTLE (0071-0805-24) |
| 0071-0803-24 | 0071-0803 | HUMAN PRESCRIPTION DRUG | Neurontin | gabapentin | CAPSULE | ORAL | 19931230 | N/A | NDA | NDA020235 | Parke-Davis Div of Pfizer Inc | GABAPENTIN | 100 mg/1 | 100 CAPSULE in 1 BOTTLE (0071-0803-24) |